COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 35 filers reported holding COMPASS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $361 | -99.6% | 183 | -99.4% | 0.00% | – |
| Q2 2023 | $92,500 | -80.2% | 29,088 | -79.7% | 0.00% | – |
| Q1 2023 | $467,417 | -26.4% | 142,941 | +13.2% | 0.00% | -100.0% |
| Q4 2022 | $635,364 | +6253.6% | 126,315 | +2686.6% | 0.00% | – |
| Q3 2022 | $10,000 | +150.0% | 4,533 | +230.9% | 0.00% | – |
| Q2 2022 | $4,000 | -96.7% | 1,370 | -96.4% | 0.00% | – |
| Q4 2021 | $120,000 | – | 37,834 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,246,977 | $2,456,545 | 3.92% |
| CHI Advisors LLC | 2,829,712 | $5,574,532 | 2.21% |
| Ally Bridge Group (NY) LLC | 914,630 | $1,801,821 | 2.12% |
| Monashee Investment Management LLC | 1,226,142 | $2,415,500 | 1.01% |
| Orbimed Advisors | 22,362,850 | $44,054,815 | 0.94% |
| Vivo Capital, LLC | 3,556,023 | $7,005,365 | 0.77% |
| CAXTON CORP | 86,773 | $170,942 | 0.65% |
| Prosight Management, LP | 935,157 | $1,842,259 | 0.58% |
| BRAIDWELL LP | 5,954,273 | $11,729,918 | 0.37% |
| Rock Springs Capital Management LP | 5,513,788 | $10,862,162 | 0.29% |